Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference150 articles.
1. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans;Adelman;Nature Reviews. Genetics,2012
2. Phase I first-in-man trial of a novel bromodomain and extra-terminal domain (BET) inhibitor (BI 894999) in patients (Pts) with advanced solid tumors;Aftimos;Journal of Clinical Oncology,2017
3. Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy;Alqahtani;Future Science OA,2019
4. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study;Amorim;Lancet Haematol,2016
5. BRD4 regulates breast cancer dissemination through Jagged1/Notch1 signaling;Andrieu;Cancer Research,2016
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells;Neoplasia;2024-11
2. BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer;Pharmacological Research;2024-10
3. An updated patent review of BRD4 degraders;Expert Opinion on Therapeutic Patents;2024-09-04
4. BRD4: an effective target for organ fibrosis;Biomarker Research;2024-08-30
5. Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC;Cell Communication and Signaling;2024-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3